Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Michelle Fullard to Parkinson Disease

This is a "connection" page, showing publications Michelle Fullard has written about Parkinson Disease.

 
Connection Strength
 
 
 
4.177
 
  1. Fullard M, Thibault D, Zisling H, Crispo JA, Willis A. Parkinson Disease Associated Differences in Elective Orthopedic Surgery Outcomes: A National Readmissions Database Analysis. J Parkinsons Dis. 2020; 10(4):1577-1586.
    View in: PubMed
    Score: 0.521
  2. Fullard ME, Willis AW. Author response: Utilization of rehabilitation therapy services in Parkinson disease in the United States. Neurology. 2018 04 24; 90(17):813.
    View in: PubMed
    Score: 0.463
  3. Fullard ME, Thibault DP, Todaro V, Foster S, Katz L, Morgan R, Kern DS, Schwalb JM, Urrea Mendoza E, Dahodwala N, Shulman L, Willis AW. Sex disparities in health and health care utilization after Parkinson diagnosis: Rethinking PD associated disability. Parkinsonism Relat Disord. 2018 03; 48:45-50.
    View in: PubMed
    Score: 0.452
  4. Fullard ME, Xie SX, Marek K, Stern M, Jennings D, Siderowf A, Willis AW, Chen-Plotkin AS. Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study. Mov Disord. 2017 Nov; 32(11):1636-1640.
    View in: PubMed
    Score: 0.444
  5. Fullard ME, Thibault DP, Hill A, Fox J, Bhatti DE, Burack MA, Dahodwala N, Haberfeld E, Kern DS, Klepitskava OS, Urrea-Mendoza E, Myers P, Nutt J, Rafferty MR, Schwalb JM, Shulman LM, Willis AW. Utilization of rehabilitation therapy services in Parkinson disease in the United States. Neurology. 2017 Sep 12; 89(11):1162-1169.
    View in: PubMed
    Score: 0.442
  6. Fullard ME, Morley JF, Duda JE. Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease. Neurosci Bull. 2017 Oct; 33(5):515-525.
    View in: PubMed
    Score: 0.442
  7. Fullard ME, Tran B, Xie SX, Toledo JB, Scordia C, Linder C, Purri R, Weintraub D, Duda JE, Chahine LM, Morley JF. Olfactory impairment predicts cognitive decline in early Parkinson's disease. Parkinsonism Relat Disord. 2016 Apr; 25:45-51.
    View in: PubMed
    Score: 0.399
  8. Bayram E, Holden SK, Fullard M, Armstrong MJ. Race and Ethnicity in Lewy Body Dementia: A Narrative Review. J Alzheimers Dis. 2023; 94(3):861-878.
    View in: PubMed
    Score: 0.160
  9. Walker IM, Fullard ME, Morley JF, Duda JE. Olfaction as an early marker of Parkinson's disease and Alzheimer's disease. Handb Clin Neurol. 2021; 182:317-329.
    View in: PubMed
    Score: 0.140
  10. Schneider RB, Jimenez-Shahed J, Abraham DS, Thibault DP, Mantri S, Fullard M, Burack MA, Chou KL, Spindler M, Jermakowicz WJ, D'Haese PF, York MK, Kirk JC, Schwalb JM, Espay AJ, Shih LC, Simon DK, Hunter C, Crispo JAG, Willis AW. Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis. Parkinsonism Relat Disord. 2020 01; 70:96-102.
    View in: PubMed
    Score: 0.130
  11. Posavi M, Diaz-Ortiz M, Liu B, Swanson CR, Skrinak RT, Hernandez-Con P, Amado DA, Fullard M, Rick J, Siderowf A, Weintraub D, McCluskey L, Trojanowski JQ, Dewey RB, Huang X, Chen-Plotkin AS. Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis. PLoS Med. 2019 10; 16(10):e1002931.
    View in: PubMed
    Score: 0.128
  12. Mantri S, Fullard M, Gray SL, Weintraub D, Hubbard RA, Hennessy S, Willis AW. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease. JAMA Neurol. 2019 01 01; 76(1):41-49.
    View in: PubMed
    Score: 0.122
  13. Chahine LM, Dos Santos C, Fullard M, Scordia C, Weintraub D, Erus G, Rosenthal L, Davatzikos C, McMillan CT. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease. Eur J Neurol. 2019 02; 26(2):246-e18.
    View in: PubMed
    Score: 0.120
  14. Mantri S, Fullard ME, Duda JE, Morley JF. Physical Activity in Early Parkinson Disease. J Parkinsons Dis. 2018; 8(1):107-111.
    View in: PubMed
    Score: 0.113
  15. Chahine LM, Xie SX, Simuni T, Tran B, Postuma R, Amara A, Oertel WH, Iranzo A, Scordia C, Fullard M, Linder C, Purri R, Darin A, Rennert L, Videnovic A, Del Riva P, Weintraub D. Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder. Parkinsonism Relat Disord. 2016 06; 27:102-6.
    View in: PubMed
    Score: 0.100
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)